4 Important Vaccines Adults Over 60 Should Consider This Flu Season

Adults aged 60 and above face a higher risk of serious complications from infectious diseases, particularly influenza and other respiratory illnesses. Older adults and people with underlying conditions such as heart disease, lung disease and diabetes may be more vulnerable to severe infections and hospitalisation.

The H1N1 strain currently circulating in India belongs to the H1N1 pdm09 family that has been present globally since the 2009 pandemic. While there is no reason for panic, health experts continue to stress the importance of preventive care for vulnerable groups, including senior citizens, young children and people with existing medical conditions.

Recent influenza activity has also highlighted the need for greater awareness among older adults. Along with seasonal influenza, infections such as dengue and chikungunya can further increase health concerns in several regions.

For adults aged 60 and above, vaccination can play an important role in reducing the severity of certain infections and lowering the risk of serious complications. Adults aged 50 and above with significant health conditions, including heart disease, chronic lung disease or diabetes, may also fall into a higher-risk category and should discuss vaccination options with their healthcare provider.

One of the key vaccines recommended for older adults is the annual influenza vaccine. Seasonal flu can lead to serious complications, hospitalisation and even death among elderly people and those with chronic illnesses. An intramuscular flu vaccine is generally recommended once every year, preferably before the flu season begins.

The pneumococcal vaccine is another important option for eligible older adults. It helps protect against infections caused by Streptococcus pneumoniae, which can lead to severe pneumonia, meningitis and bloodstream infections. Conditions such as diabetes, chronic obstructive pulmonary disease and chronic kidney disease can increase the risk of serious pneumococcal illness. A single dose of PCV20 may provide broad protection, while PCV13 followed by PPSV23 can be considered as an alternative where appropriate.

Older adults should also review their protection against tetanus, diphtheria and pertussis through the Tdap vaccine. Immunity gained from childhood vaccinations can decline over time, while illnesses such as whooping cough can be particularly concerning for people with existing respiratory conditions. Adults who have not received Tdap during adulthood may require a dose, followed by a Td or Tdap booster every 10 years, depending on medical advice and vaccination history.

COVID-19 boosters may also be recommended periodically for older adults and people with underlying health conditions, based on current national health guidance. Updated vaccination recommendations can vary over time, making it important to follow the latest advice from healthcare authorities and doctors.

Vaccines do not necessarily prevent every infection, but they can help reduce the severity of illness and lower the chances of serious complications in eligible individuals. Older adults should speak with a qualified healthcare professional to determine which vaccines are suitable based on their age, previous vaccinations, medical history and existing health conditions.